Hypothesis

Rapamycin does not merely suppress mTOR; it imposes a temporal gate on JNK/AP-1 signaling that allows brief, protective pulses while preventing the transition to sustained SASP-driven inflammation. This kinetic checkpoint uncouples stress‑induced hormesis from inflammaging, explaining why lifespan extends without removing the underlying damage.

Mechanistic Basis

mTOR inhibition reduces phosphorylation of 4E-BP1 and S6K, lowering translational load and attenuating the feed‑forward loop where hyperactive translation fuels mitochondrial ROS production [1]. Reduced ROS limits the amplitude of mitochondrial damage‑activated JNK. Simultaneously, rapamycin enhances the expression of dual‑specificity phosphatases (DUSPs) that dephosphorylate JNK, shortening its active half‑life [2]. The result is a biphasic JNK profile: an early, transient peak that drives antioxidant genes (e.g., GCLC, SOD2) via AP‑1, followed by rapid return to baseline. Furthermore, rapamycin‑mediated reduction of mTORC1 activity diminishes S6K‑dependent phosphorylation of IRS‑1, alleviating insulin‑like feedback inhibition and preserving Akt‑mediated FOXO phosphorylation, which promotes nuclear translocation of FOXO transcription factors that cooperate with transient AP‑1 to upregulate DNA‑repair genes (e.g., GADD45A) without triggering SASP. In contrast, without rapamycin, persistent mTOR signaling sustains ROS, maintains JNK activity, and drives AP‑1‑dependent transcription of SASP components (IL‑6, IL‑1β, COX‑2) [3].

Testable Predictions

1. Phospho‑JNK kinetics – In aged mice treated with rapamycin, immunoblot time‑course after an acute oxidative stress (e.g., H2O2) will show a higher early peak (0‑30 min) but a faster return to baseline by 2 h compared with vehicle, measurable by densitometry [2].
2. SASP suppression despite JNK pulse – RNA‑seq of sorted senescent fibroblasts will reveal that rapamycin‑treated cells retain the early‑phase AP‑1 transcriptional signature (e.g., FOSL1, JUNB) but lack late‑phase SASP genes (IL6, IL1B, CXCL8) after 24 h stress [3].
3. DUSP dependence – Genetic knock‑down of DUSP1 in rapamycin‑treated animals will abolish the rapid JNK dephosphorylation, restoring prolonged SASP expression and shortening lifespan, confirming the phosphatase gate [2].
4. FOXO‑AP‑1 co‑occupancy – ChIP‑seq for FOXO1 and c‑Jun in rapamycin‑treated senescent cells will show increased co‑binding at promoters of DNA‑repair genes (e.g., GADD45A, XRCC1) but not at classic SASP loci (IL6, IL1B) after oxidative stress, indicating a transient, protective AP‑1‑FOXO module.

If any of these predictions fail, the hypothesis that rapamycin’s longevity effect relies on gating JNK/AP-1 dynamics rather than damage repair would be falsified.